Thus, PLT hyperactivity in RA leads to excessive aggregation, which can alter their immunoregulatory functions by limiting interactions with immune cells and reducing the release of anti-inflammatory mediators such as TGF-β and PD-L1 [24,25]. The gene discussed is TGFB1; the disease is rheumatoid arthritis.